Abstract
The aim of this chapter is to identify cancers that to date have been associated with obesity and to highlight the leading physiologic theories linking obesity and cancer. The chapter will then explore the validity of national and international recommendations to reduce adiposity, when appropriate, for the purpose of lowering cancer incidence as well as risk for cancer recurrence. Finally, as a result of bariatric surgery the opportunity has been advanced to investigate whether or not long-term voluntary weight loss for overweight or obesity is associated with reduced cancer risk and lower cancer-related mortality. Finally, the chapter will review cancer risk and cancer mortality subsequent to bariatric surgery, with brief mention of cancer diagnosis incidental to weight loss surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32(2):287–94.
Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA. 2002;288(14):1758–61.
Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163(18):2146–8.
Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115(12):1544–50.
Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009;119(13):1728–35.
Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138–45.
Preston SH. Deadweight?–The influence of obesity on longevity. N Engl J Med. 2005;352(11):1135–7.
Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR: World Cancer Research Fund/American Institute for Cancer Research;2007.
Patlak M, Nass SJ. The role of obesity in cancer survival and recurrence: Workshop summary. Washington, DC: Institute of Medicine of the National Academies; 2012.
National Institutes of Health (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6(2):51S–209.
National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2000;160:898–904.
Calle E. Obesity and cancer (Chapter 10). In: Hu F, editor. Obesity Epidemiolog. Oxford: Oxford University Press; 2008. p. 196–215.
Reeves G, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Woman Study: cohort study. Br Med J. 2007;335:1134–9.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.
Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer. 2005;93(9):1062–7.
Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni Jr JF. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17(7):901–9.
Renehan A, Tyson M, Egger M, Heller R, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.
Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23(38):6365–78.
IARC. IRAC handbooks of cancer prevention weight control and physical activity. Lyon: International Agency for Research on Cancer; 2002.
Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst. 2004;96(21):1635–8.
Rodriguez C, Freedland SJ, Deka A, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2007;16(1):63–9.
Xu WH, Xiang YB, Zheng W, et al. Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol. 2006;35(1):159–66.
Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23(4):843–52.
Calle EE. Obesity and cancer. BMJ. 2007;335(7630):1107–8.
Basen-Engquist K, Chang M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep. 2011;13(1):71–6.
Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev. 2002;11 Suppl 2:S94–100.
Anderson AS, Caswell S. Obesity management–an opportunity for cancer prevention. Surgeon. 2009;7(5):282–5.
Yaari S, Goldbourt U. Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol. 1998;148(6):546–55.
Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol. 1999;149(6):491–503.
Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91.
Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11(12):886–95.
Kolonin MG, editor. Adipose tissue and cancer. New York: Springer Science; 2013.
Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.
Force USPST, Barton M. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. Pediatrics. 2010;125(2):361–7.
Whitlock EP, O’Connor EA, Williams SB, Beil TL, Lutz KW. Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF. Pediatrics. 2010;125(2):e396–418.
USPSTF. Screening and interventions for obesity in adults: Summary of the evidence by the U.S. Preventive Services Task Force. 2010; http://www.uspreventiveservicestaskforce.org/3rduspstf/obesity/obessum2.htm
Wang Y, Beydoun MA. The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28.
Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303(3):242–9.
Ogden CL, Lamb MM, Carroll MD, Flegal KM. Obesity and socioeconomic status in children and adolescents: United States, 2005-2008. NCHS Data Brief. 2010;2010(51):1–8.
Reilly JJ, Methven E, McDowell ZC, et al. Health consequences of obesity. Arch Dis Child. 2003;88(9):748–52.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.
Thompson DR, Obarzanek E, Franko DL, et al. Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 2007;150(1):18–25.
Jasik CB, Lustig RH. Adolescent obesity and puberty: the “perfect storm”. Ann N Y Acad Sci. 2008;1135:265–79.
Petridou E, Syrigou E, Toupadaki N, Zavitsanos X, Willett W, Trichopoulos D. Determinants of age at menarche as early life predictors of breast cancer risk. Int J Cancer. 1996;68(2):193–8.
Titus-Ernstoff L, Longnecker MP, Newcomb PA, et al. Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998;7(9):783–9.
Stoll BA. Western diet, early puberty, and breast cancer risk. Breast Cancer Res Treat. 1998;49(3):187–93.
Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67.
Boyle P, Autier P, Bartelink H, et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol. 2003;14(7):973–1005.
Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114(1):82–96.
Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61–78.
The 2010 Dietary Guidelines for Americans. Washington, DC: US Department of Agriculture and the US Department of Health and Human Services; 2010.
Physical Activity Guidelines for Americans. Washington, DC: US Department of Health and Human Services; 2008.
Wolin KY, Colditz GA. Can weight loss prevent cancer? Br J Cancer. 2008;99(7):995–9.
Adams TD, Hunt SC. Cancer and obesity: effect of bariatric surgery. World J Surg. 2009;33(10):2028–33.
Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes Obes Metab. 2011;13(12):1063–72.
Birks S, Peeters A, Backholer K, O’Brien P, Brown W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev. 2012;13(10):868–91.
Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg. 2002;184(6B):9S–16.
Knowler WC, Barrett-Conner E, Fowler SE. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
Look ARG, Pi-Sunyer X, Blackburn G, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374–83.
Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.
Wadden TA, West DS, Neilberg RH, et al. One-year weight losses in the Look AHEAD study: Factors associated with success. Obesity. 2009;17(4):713–22.
Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610–28.
McTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 2010;28(26):4074–80.
Rapp K, Klenk J, Ulmer H, et al. Weight change and cancer risk in a cohort of more than 65,000 adults in Austria. Ann Oncol. 2008;19(4):641–8.
Ahn J, Schatzkin A, Lacey Jr JV, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007;167(19):2091–102.
Parker E, Folsom A. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women’s Health Study. Int J Obese Relat Metab Disord. 2003;27:1447–52.
Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Weight change and risk of endometrial cancer. Int J Epidemiol. 2006;35(1):151–8.
Harvie M, Howell A, Vierkant RA, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev. 2005;14(3):656–61.
Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–78.
Webb P. Commentary: weight gain, weight loss, and endometrial cancer. Int J Epidemiol. 2006;35(1):301–2.
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.
Radimer KL, Ballard-Barbash R, Miller JS, et al. Weight change and the risk of late-onset breast cancer in the original Framingham cohort. Nutr Cancer. 2004;49(1):7–13.
Eng SM, Gammon MD, Terry MB, et al. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol. 2005;162(3):229–37.
Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007;298(3):289–98.
Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):629–42.
Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst. 2006;98(24):1767–76.
Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol. 1995;141(12):1128–41.
Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2010;3(11):1451–61.
Ligibel J. Obesity and breast cancer. Oncology. 2011;25(11):994–1000.
Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123(3):627–35.
Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in the transition. Washington, DC: Institute of Medicine and National Research Council; 2005.
Demark-Wahnefried W, Campbell KL, Hayes SC. Weight management and its role in breast cancer rehabilitation. Cancer. 2012;118(8 Suppl):2277–87.
Joshu CE, Mondul AM, Menke A, et al. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila). 2011;4(4):544–51.
Ashrafian H, Ahmed K, Rowland SP, et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer. 2011;117(9):1788–99.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256e245.
Courcoulas AP. Progress in filling the gaps in bariatric surgery. JAMA. 2012;308(11):1160–1.
Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.
Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006;81(10 Suppl):S46–51.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
Monti V, Carlson JJ, Hunt SC, Adams TD. Relationship of ghrelin and leptin hormones with body mass index and waist circumference in a random sample of adults. J Am Diet Assoc. 2006;106(6):822–8.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.
MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1(3):213–20.
Kaul A, Sharma J. Impact of bariatric surgery on comorbidities. Surg Clin North Am. 2011;91(6):1295-1312, ix.
Menendez P, Padilla D, Villarejo P, Menendez JM, Lora D. Does bariatric surgery decrease gastric cancer risk? Hepatogastroenterology. 2012;59(114):409–12.
De Roover A, Detry O, Desaive C, et al. Risk of upper gastrointestinal cancer after bariatric operations. Obes Surg. 2006;16(12):1656–61.
Renehan AG. Bariatric surgery, weight reduction, and cancer prevention. Lancet Oncol. 2009;10(7):640–1.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.
Sjostrom L, Gummesson A, Sjostrom CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23.
Christou NV, Lieberman M, Sampalis F, Sampalis JS. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.
Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg. 2010;252(6):972–6.
McCawley GM, Ferriss JS, Geffel D, Northup CJ, Modesitt SC. Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg. 2009;208(6):1093–8.
Gagne DJ, Papasavas PK, Maalouf M, Urbandt JE, Caushaj PF. Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis. 2009;5(2):160–4.
Sjostrom L. Surgical intervention as a strategy for treatment of obesity. Endocrine. 2000;13(2):213–30.
Sjostrom L, Lonn L, Chowdhury B. The sagittal diameter is a valid marker of visceral adipose tissue volume. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Medelson R, editors. Recent advances in obesity research VII. London: John Libbey; 1996. p. 309–19.
Johnson C, Adamo M. The SEER Program: coding and staging manual 2007. Bethesda: Surveillance Research Program, Cancer Statistics Branch, Division of Cancer Control and Population Sciences, National Institutes of Health; 2007. NIH Pub. No. 07-5581.
Sainsbury A, Goodlad RA, Perry SL, Pollard SG, Robins GG, Hull MA. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1401–10.
Acknowledgments
We wish to thank Maureen Rice of the McMaster University Evidence-based Practice Center (MU-EPC), McMaster University, Hamilton, Ontario, for conducting a medical literature review. We also express appreciation to Kenneth Adams, Ph.D.; the late Eugenia Calle, Ph.D.; Paul Hopkins, M.D.; Richard Gress, M.S.; Nan Stroup, Ph.D.; Sherman Smith, M.D.; Steven Simper, M.D.; and Rodrick McKinlay, M.D.
T.D.A. receives partial funding through the Huntsman Fellowship—Advancing Community Cancer Prevention, Intermountain Research and Medical Foundation, Intermountain Healthcare Corporation, SLC, UT. T.D.A., S.C.H., and L.E.D. are supported by grant DK-55006 from the National Institutes of Health/the National Institute of Diabetes and Digestive and Kidney Diseases.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Review Questions and Answers
Review Questions and Answers
- a.
Question 1: Do pre-menopausal obese women have a greater risk for incidence of breast cancer compared to pre-menopausal normal weight women?
- Answer 1:
No, population-based research suggests that pre-menopausal obese women are at lower risk for developing breast cancer compared to pre-menopausal normal weight women. However, post-menopausal obese women are at a greater risk for breast cancer compared to post-menopausal normal weight women.
- b.
Question 2: What are considered to be the primary mechanistic links between obesity and specific cancer types?
- Answer 2:
Generally, three major categories have been identified as mechanisms associating obesity and obesity-related cancers. These include chronic inflammation, over-release of steroid-related hormones and tumor growth promotion (secondary to hyperinsulinemia.
- c.
Question 3: How strongly does the evidence support the recommendation that traditional weight loss reducesincident risk of cancer as well as cancer recurrence?
- Answer 3:
The evidence relating weight loss from traditional therapies (i.e. diet, physical activity and behavioral modification) and reduced cancer risk are limited primarily because of the difficulty achieving significant and sustained weight loss among overweight and obese population groups.
- d.
Question 4: What is the evidence for reduced cancer incidence and cancer mortality among patients who have had bariatric surgery compared to obese, non-bariatric surgical subjects?
- Answer 4:
Because patients who have undergone bariatric surgery generally lose a large amount of weight (i.e. greater than 20% of initial weight) and maintain significant weight loss for an extended period of time (i.e. years), these patients are ideal to study weight loss and subsequent cancer risk. There are multiple studies that have shown when bariatric cancer patients are compared to severely obese non-surgical subjects, the bariatric surgical patients demonstrate lower cancer mortality and cancer incidence when compared to severely obese non-operated controls.
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Adams, T.D., Hunt, S.C., Davidson, L.E., Hashibe, M. (2015). 50 Obesity and Cancer with Emphasis on Bariatric Surgery. In: Brethauer, S., Schauer, P., Schirmer, B. (eds) Minimally Invasive Bariatric Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1637-5_50
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1637-5_50
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1636-8
Online ISBN: 978-1-4939-1637-5
eBook Packages: MedicineMedicine (R0)